PHI 45/24 Prescribed List Cost Recovery Implementation Statement 2024-25

The 2024-25 Cost Recovery Implementation Statement (CRIS) for administration of the Prescribed List of Medical Devices and Human Tissue Products has been published.

Date published:
PHI circular type:
Prescribed List announcement
Audience:
Health sector

The CRIS provides information to the medical devices industry and other stakeholders on how the department implements cost recovery for the administration of the Prescribed List to comply with the Australian Government Charging Framework and Cost Recovery Policy.

The 2024-25 Prescribed List CRIS is now available at: Cost Recovery Implementation Statement – Administration of the Prostheses List

Public consultation on the draft CRIS was from 8 May 2024 to 29 May 2024, and the final CRIS includes a summary of stakeholder feedback and responses from the department.

For any queries please contact: PLcostrecovery@Health.gov.au.